These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31959747)

  • 21. The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function.
    Mapperley C; van de Lagemaat LN; Lawson H; Tavosanis A; Paris J; Campos J; Wotherspoon D; Durko J; Sarapuu A; Choe J; Ivanova I; Krause DS; von Kriegsheim A; Much C; Morgan M; Gregory RI; Mead AJ; O'Carroll D; Kranc KR
    J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33156926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. m
    Boo SH; Ha H; Kim YK
    Cell Rep; 2022 Sep; 40(10):111317. PubMed ID: 36070699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. YTHDF2 Regulates Cell Growth and Cycle by Facilitating KDM1A mRNA Stability.
    Li X; Zhang K; Hu Y; Luo N
    Am J Pathol; 2023 Apr; 193(4):442-455. PubMed ID: 36681189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. YTHDF3 facilitates translation and decay of N
    Shi H; Wang X; Lu Z; Zhao BS; Ma H; Hsu PJ; Liu C; He C
    Cell Res; 2017 Mar; 27(3):315-328. PubMed ID: 28106072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N6-methyladenosine-dependent regulation of messenger RNA stability.
    Wang X; Lu Z; Gomez A; Hon GC; Yue Y; Han D; Fu Y; Parisien M; Dai Q; Jia G; Ren B; Pan T; He C
    Nature; 2014 Jan; 505(7481):117-20. PubMed ID: 24284625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The m
    Qin Y; Qiao Y; Li L; Luo E; Wang D; Yao Y; Tang C; Yan G
    Life Sci; 2021 Jun; 274():119366. PubMed ID: 33741419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YTHDF2/3 Are Required for Somatic Reprogramming through Different RNA Deadenylation Pathways.
    Liu J; Gao M; Xu S; Chen Y; Wu K; Liu H; Wang J; Yang X; Wang J; Liu W; Bao X; Chen J
    Cell Rep; 2020 Sep; 32(10):108120. PubMed ID: 32905781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. YTHDF2 promotes multiple myeloma cell proliferation via STAT5A/MAP2K2/p-ERK axis.
    Hua Z; Wei R; Guo M; Lin Z; Yu X; Li X; Gu C; Yang Y
    Oncogene; 2022 Mar; 41(10):1482-1491. PubMed ID: 35075244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer.
    Einstein JM; Perelis M; Chaim IA; Meena JK; Nussbacher JK; Tankka AT; Yee BA; Li H; Madrigal AA; Neill NJ; Shankar A; Tyagi S; Westbrook TF; Yeo GW
    Mol Cell; 2021 Aug; 81(15):3048-3064.e9. PubMed ID: 34216543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells.
    Li J; Wu L; Pei M; Zhang Y
    J Ovarian Res; 2020 Sep; 13(1):111. PubMed ID: 32948220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. YTH domain family 2 orchestrates epithelial-mesenchymal transition/proliferation dichotomy in pancreatic cancer cells.
    Chen J; Sun Y; Xu X; Wang D; He J; Zhou H; Lu Y; Zeng J; Du F; Gong A; Xu M
    Cell Cycle; 2017; 16(23):2259-2271. PubMed ID: 29135329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency.
    Wang X; Zhao BS; Roundtree IA; Lu Z; Han D; Ma H; Weng X; Chen K; Shi H; He C
    Cell; 2015 Jun; 161(6):1388-99. PubMed ID: 26046440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FTO regulates myoblast proliferation by controlling CCND1 expression in an m
    Deng K; Zhang Z; Ren C; Liang Y; Gao X; Fan Y; Wang F
    Exp Cell Res; 2021 Apr; 401(2):112524. PubMed ID: 33651996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone lactylation drives oncogenesis by facilitating m
    Yu J; Chai P; Xie M; Ge S; Ruan J; Fan X; Jia R
    Genome Biol; 2021 Mar; 22(1):85. PubMed ID: 33726814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. m
    Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y
    Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Knockdown of YTH N
    Zhang J; Pi J; Liu Y; Yu J; Feng T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Dec; 33(12):1628-1634. PubMed ID: 29382422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Mechanisms Driving mRNA Degradation by m
    Lee Y; Choe J; Park OH; Kim YK
    Trends Genet; 2020 Mar; 36(3):177-188. PubMed ID: 31964509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma.
    Fang R; Chen X; Zhang S; Shi H; Ye Y; Shi H; Zou Z; Li P; Guo Q; Ma L; He C; Huang S
    Nat Commun; 2021 Jan; 12(1):177. PubMed ID: 33420027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of Early B Cell Development by the RNA N
    Zheng Z; Zhang L; Cui XL; Yu X; Hsu PJ; Lyu R; Tan H; Mandal M; Zhang M; Sun HL; Sanchez Castillo A; Peng J; Clark MR; He C; Huang H
    Cell Rep; 2020 Jun; 31(13):107819. PubMed ID: 32610122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoribonucleolytic Cleavage of m
    Park OH; Ha H; Lee Y; Boo SH; Kwon DH; Song HK; Kim YK
    Mol Cell; 2019 May; 74(3):494-507.e8. PubMed ID: 30930054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.